Fig. 7From: Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experienceProfile of the tumour dose in the patient along the neutron beam central axis: RBE-weighted dose with UMR-106 factors (Table 2), RBE-weighted dose with KURRI factors, and photon iso-effective dose with UMR-106 cell survival parameters (Table 1)Back to article page